Literature DB >> 10454264

Inhibition of liver glutathione S-transferase placental form-positive foci development in the rat hepatocarcinogenesis by Porphyra tenera (Asakusa-nori).

T Ichihara1, H Wanibuchi, T Taniyama, Y Okai, Y Yano, S Otani, S Imaoka, Y Funae, S Fukushima.   

Abstract

The effects of Asakusa-nori, Porphyra tenera (PT), a popular edible seaweed in Japan, on the development of putative preneoplastic lesions, glutathione S-transferase placental form (GST-P)-positive foci, in the male F344 rat liver were examined using a medium-term bioassay system. PT significantly decreased both the number and area of GST-P-positive foci in rat livers initiated with diethylnitrosamine (DEN). To investigate possible mechanisms of inhibition, effects of PT on 5-bromo-2'-deoxyuridine (BrdU) labeling in GST-P-positive foci and the surrounding area of hepatocytes were studied. The ratio of the GST-P-positive foci to surrounding tissue labeling indices was decreased in the PT-treated group as compared with the DEN alone group. Ornithine decarboxylase activity in the liver was slightly increased and spermidine/spermine N'-acetyltransferase activity was slightly decreased in the PT-treated animals. These results suggest that PT possesses chemopreventive effects against DEN-induced hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454264     DOI: 10.1016/s0304-3835(99)00106-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

Review 1.  Health Functionality and Quality Control of Laver (Porphyra, Pyropia): Current Issues and Future Perspectives as an Edible Seaweed.

Authors:  Tae Jin Cho; Min Suk Rhee
Journal:  Mar Drugs       Date:  2019-12-23       Impact factor: 5.118

2.  In Vitro and In Vivo Anticancer Effects of Sterol Fraction from Red Algae Porphyra dentata.

Authors:  Katarzyna Kazłowska; Hong-Ting Victor Lin; Shun-Hsien Chang; Guo-Jane Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-26       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.